MassDevice.com +5 | The top 5 medtech stories for May 17, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters. 5. Biostage unveils $5 million offering for organ regeneration tech Organ regeneration specialist Biostage, formerly know as Harvard Apparatus Regenerative Technology, announced that it will offer $5 million worth of common stock May 19 to fund its ongoing R&D efforts. BSTG shares closed down -3.5% at $1.65 apiece yesterday on the news. Read more 4. Staar Surgical wins Health Canada nod as shares hit 52-week low Implantable contact lens maker Staar Surgical said it earned Health Canada approval to sell its EVO Visian ICL in the country. The device to correct myopia and astigmatism is permanently implanted between the iris and the eye’s natural lens. Staar sells 3 implantable lenses under its Visian franchise, but none are available in the U.S., according to the company’s website. Read more 3. BioVentrix touts 1st-in-human procedure for Revivent device BioVentrix said it successfully implanted its micro-anchor Revivent device into a 64-year-old female patient suffering from heart failure symptoms following a heart attack. The first-in-human test follows a s...
Conclusions: It appears that further studies are necessary to explain this problem, perhaps to include an evaluation of TF levels in psoriatic skin. PMID: 31616219 [PubMed]
Abstract Heart failure with reduced ejection fraction (HFrEF) is a progressive clinical syndrome commonly associated with left ventricle dilatation and characterized by reduced cardiac output, secondary pulmonary and systemic venous congestion, and inadequate peripheral oxygen delivery. It is common yet complex and requires synthesis of evidence-based guidelines along with strong clinical acumen. The following is a review of an illustrative case that highlights the important clinical considerations in diagnosis, assessment, and management of HFrEF commonly encountered in practice. Explanations provided highlight o...
Abstract The cumulative incidence of systolic heart failure is similar in men and women. However, major prognostic differences exist between genders. We sought to measure gender differences in furosemide prescribing patterns for patients with preexisting heart failure with reduced ejection fraction (HFrEF) admitted with Stage C acute decompensation, regardless of the underlying cause. We conducted a single-center retrospective analysis of patients admitted between 2015 and 2018 for acute on chronic decompensated HFrEF. Primary outcomes were differences in initial furosemide dose, total dose over the first 24&thins...
Authors: Gąsiorek P, Sakowicz A, Banach M, von Haehling S, Bielecka-Dabrowa A Abstract Purpose: The study is aimed at identifying echocardiographic and circulating biomarkers as well as hemodynamic indices of embolic stroke of undetermined etiology (ESUS) in patients aged
CONCLUSION: The combination of recession and resection procedures with nasal loop myopexy was found to be effective in correcting the ocular deviation and limitation to elevation in abduction by correcting the deflected course of superior rectus and medial rectus to result in an effective improvement of elevation in abduction. One case had an overcorrection of exotropia. There were no other major complications. PMID: 31612771 [PubMed - as supplied by publisher]
Condition: Rectal Prolapse Intervention: Device: CELLIS Rectopexy (Porcine Acellular Dermal Matrix, PADM) Sponsor: Meccellis Biotech Not yet recruiting
Condition: Myocardial Infarction Intervention: Other: No intervention Sponsor: Medical University of Graz Not yet recruiting
Conditions: Heart Failure，Congestive; Drug Use; Patient Care Intervention: Behavioral: Educational outreach visit Sponsor: Region Skane Not yet recruiting
This study implemented congestive heart failure self-management education in primary care using a holistic multidisciplinary approach with SMA to provide evidence-based interventions to improve depression, QOL, and health promotion outcomes. Patients participating in the holistic multidisciplinary SMA experienced improvement in depression, QOL, and health promotion behaviors. A comparison of the means between preintervention and postintervention showed an overall reduction in systolic blood pressure, weight, depression scores, QOL scores, and several indicators of health promotion lifestyle.
Publication date: November 2019Source: The Lancet Diabetes &Endocrinology, Volume 7, Issue 11Author(s): Naveed Sattar, David Preiss